BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35114556)

  • 1. Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Yoshida Y; Chen Z; Baudier RL; Krousel-Wood M; Anderson AH; Fonseca VA; Mauvais-Jarvis F
    Atherosclerosis; 2022 Mar; 344():13-19. PubMed ID: 35114556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women.
    Yoshida Y; Chen Z; Baudier RL; Krousel-Wood M; Anderson AH; Fonseca VA; Mauvais-Jarvis F
    Diabetes Care; 2021 Nov; 44(11):2564-2572. PubMed ID: 34475032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in 10-year ischemic cardiovascular disease risk prediction in Chinese patients with prediabetes and type 2 diabetes.
    Yang L; Fish AF; Zhu Y; Yuan X; Li J; Wang X; Yuan L; Jia Z; Liu C; Xu Y; Lou Q
    BMC Cardiovasc Disord; 2019 Dec; 19(1):301. PubMed ID: 31881945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: analysis of the Korea National Health Insurance Service Database.
    Kim JE; Choi J; Park J; Shin A; Choi NK; Choi JY
    Menopause; 2021 Sep; 28(11):1225-1232. PubMed ID: 34520413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-dimensional characterization of prediabetes in the Project Baseline Health Study.
    Chatterjee R; Kwee LC; Pagidipati N; Koweek LH; Mettu PS; Haddad F; Maron DJ; Rodriguez F; Mega JL; Hernandez A; Mahaffey K; Palaniappan L; Shah SH;
    Cardiovasc Diabetol; 2022 Jul; 21(1):134. PubMed ID: 35850765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
    Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes.
    Sinha A; Ning H; Cameron N; Bancks M; Carnethon MR; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
    J Card Fail; 2023 Mar; 29(3):246-254. PubMed ID: 36343785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
    Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
    Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review.
    Paschou SA; Athanasiadou KI; Papanas N
    Diabetes Ther; 2024 Apr; 15(4):741-748. PubMed ID: 38363540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Chu JH; Michos ED; Ouyang P; Vaidya D; Blumenthal RS; Budoff MJ; Blaha MJ; Whelton SP
    Am J Prev Cardiol; 2022 Sep; 11():100362. PubMed ID: 35769201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
    Gu Y; Han F; Xue M; Wang M; Huang Y
    BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression from different blood glucose states to cardiovascular diseases: a prospective study based on multi-state model.
    Chen Y; Xu L; Cheng Z; Zhang D; Yang J; Yin C; Li S; Li J; Hu Y; Wang Y; Liu Y; Wang Z; Zhang L; Chen R; Dou Q; Bai Y
    Eur J Prev Cardiol; 2023 Oct; 30(14):1482-1491. PubMed ID: 37315161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Plu-Bureau G; Mounier-Vehier C
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):438-447. PubMed ID: 33757923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
    Saeed A; Sun W; Agarwala A; Virani SS; Nambi V; Coresh J; Selvin E; Boerwinkle E; Jones PH; Ballantyne CM; Hoogeveen RC
    Atherosclerosis; 2019 Mar; 282():52-56. PubMed ID: 30685442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat distribution, menopausal hormone therapy and incident type 2 diabetes in postmenopausal women of the MESA study.
    Ebong IA; Watson KE; Hairston KG; Carnethon MR; Ouyang P; Szklo M; Bertoni AG
    Maturitas; 2016 Sep; 91():147-52. PubMed ID: 27451334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and diabetes: EMAS clinical guide.
    Slopien R; Wender-Ozegowska E; Rogowicz-Frontczak A; Meczekalski B; Zozulinska-Ziolkiewicz D; Jaremek JD; Cano A; Chedraui P; Goulis DG; Lopes P; Mishra G; Mueck A; Rees M; Senturk LM; Simoncini T; Stevenson JC; Stute P; Tuomikoski P; Paschou SA; Anagnostis P; Lambrinoudaki I
    Maturitas; 2018 Nov; 117():6-10. PubMed ID: 30314563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
    Zhao D; Guallar E; Ouyang P; Subramanya V; Vaidya D; Ndumele CE; Lima JA; Allison MA; Shah SJ; Bertoni AG; Budoff MJ; Post WS; Michos ED
    J Am Coll Cardiol; 2018 Jun; 71(22):2555-2566. PubMed ID: 29852978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of hormone therapy among women with hysterectomy/oophorectomy.
    Chen L; Mishra GD; Dobson AJ; Wilson LF; Jones MA
    Hum Reprod; 2017 Apr; 32(4):885-892. PubMed ID: 28184451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.